174 related articles for article (PubMed ID: 30222360)
1. Improved Cancer Immunochemotherapy via Optimal Co-delivery of Chemotherapeutic and Immunomodulatory Agents.
Chen Y; Sun J; Huang Y; Lu B; Li S
Mol Pharm; 2018 Nov; 15(11):5162-5173. PubMed ID: 30222360
[TBL] [Abstract][Full Text] [Related]
2. Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy.
Sun J; Wan Z; Chen Y; Xu J; Luo Z; Parise RA; Diao D; Ren P; Beumer JH; Lu B; Li S
Acta Biomater; 2020 Apr; 106():289-300. PubMed ID: 32004652
[TBL] [Abstract][Full Text] [Related]
3. An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy.
Chen Y; Xia R; Huang Y; Zhao W; Li J; Zhang X; Wang P; Venkataramanan R; Fan J; Xie W; Ma X; Lu B; Li S
Nat Commun; 2016 Nov; 7():13443. PubMed ID: 27819653
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma Immunochemotherapy: Targeted Delivery of Doxorubicin via a Dual Functional Nanocarrier.
Zhai Q; Chen Y; Xu J; Huang Y; Sun J; Liu Y; Zhang X; Li S; Tang S
Mol Pharm; 2017 Nov; 14(11):3888-3895. PubMed ID: 28850241
[TBL] [Abstract][Full Text] [Related]
5. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
[TBL] [Abstract][Full Text] [Related]
6. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.
Zhang X; Liu K; Huang Y; Xu J; Li J; Ma X; Li S
Bioconjug Chem; 2014 Sep; 25(9):1689-96. PubMed ID: 25121577
[TBL] [Abstract][Full Text] [Related]
7. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
[TBL] [Abstract][Full Text] [Related]
8. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel.
Xu J; Zhang X; Chen Y; Huang Y; Wang P; Wei Y; Ma X; Li S
Mol Pharm; 2017 Jan; 14(1):31-41. PubMed ID: 28043124
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
[TBL] [Abstract][Full Text] [Related]
10. PEG-Fmoc-Ibuprofen Conjugate as a Dual Functional Nanomicellar Carrier for Paclitaxel.
Zhao M; Huang Y; Chen Y; Xu J; Li S; Guo X
Bioconjug Chem; 2016 Sep; 27(9):2198-205. PubMed ID: 27532881
[TBL] [Abstract][Full Text] [Related]
11. Codelivered Chemotherapeutic Doxorubicin
Lan Y; Liang Q; Sun Y; Cao A; Liu L; Yu S; Zhou L; Liu J; Zhu R; Liu Y
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31904-31921. PubMed ID: 32551517
[TBL] [Abstract][Full Text] [Related]
12. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
Zhang X; Huang Y; Zhao W; Chen Y; Zhang P; Li J; Venkataramanan R; Li S
Mol Pharm; 2014 Aug; 11(8):2807-14. PubMed ID: 24987803
[TBL] [Abstract][Full Text] [Related]
13. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel.
Zhang P; Huang Y; Liu H; Marquez RT; Lu J; Zhao W; Zhang X; Gao X; Li J; Venkataramanan R; Xu L; Li S
Biomaterials; 2014 Aug; 35(25):7146-56. PubMed ID: 24856103
[TBL] [Abstract][Full Text] [Related]
14. NLG919/cyclodextrin complexation and anti-cancer therapeutic benefit as a potential immunotherapy in combination with paclitaxel.
Xu J; Ren X; Guo T; Sun X; Chen X; Patterson LH; Li H; Zhang J
Eur J Pharm Sci; 2019 Oct; 138():105034. PubMed ID: 31382032
[TBL] [Abstract][Full Text] [Related]
15. Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer.
Diao D; Zhai J; Yang J; Wu H; Jiang J; Dong X; Passaro A; Aramini B; Rao S; Cai K
Transl Lung Cancer Res; 2021 Feb; 10(2):926-935. PubMed ID: 33718033
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
18. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.
Lu J; Huang Y; Zhao W; Marquez RT; Meng X; Li J; Gao X; Venkataramanan R; Wang Z; Li S
Biomaterials; 2013 Feb; 34(5):1591-600. PubMed ID: 23182923
[TBL] [Abstract][Full Text] [Related]
19. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
